Therapeutic Drug Levels to Achieve Good Eular Response in Patients with Rheumatoid Arthritis Receiving Adalimumab: Results From the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (braggss) Cohort

RM Hum, P. Ho, N Nair, D Plant, A Morgan, J Isaacs, A. G. Wilson, K Hyrich, A Barton

Research output: Contribution to conferenceAbstract

Original languageEnglish
Number of pages2
Publication statusPublished - Jun 2022

Cite this